Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Intravenous Heroin Use on Immune Activation in Treated HIV

NCT03976258 is registered in ClinicalTrials.gov with MetroHealth Medical Center as lead sponsor.

NCT NCT03976258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03976258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Intravenous Heroin Use on Immune Activation in Treated HIV
Lead sponsor
MetroHealth Medical Center
Phase
Observational
Overall status
Completed
Start date
July 14, 2017
Completion date
December 31, 2022
Enrollment
190 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, hiv infection, opioid-use disorder